Solovis, a multi-asset class portfolio management, analytics and reporting platform for limited partners and asset allocators, today announced the acquisition of Madrone Software & Analytics, Inc. a provider of portfolio, risk analytics and market intelligence for the asset management industry. With the acquisition of Madrone, Solovis clients gain access to advanced fund analytics, detailed risk analysis, and operational and investment due diligence capabilities – enabling them to make better strategic portfolio decisions.
The purchase of Madrone, based in San Francisco, CA, aligns with Solovis’ strategy to deliver a single technology platform for configurable, multi-asset class reporting that factors in performance, risk, exposure, liquidity, and fund-level transparency and aggregation. Asset owners and asset managers will now be able leverage Madrone’s behavioral-based analytics within Solovis’ highly configurable platform to more accurately measure portfolio and organizational skill and risk.
New tools for predicting lupus flares now one step closer to market.
Lead investor i2E, along with Chicago-based OCA Ventures and Mayo Clinic Ventures, has funded the first round of investment to assist Progentec in creating the first-ever commercial test to predict the onset of lupus flares. Technology created by the Oklahoma Medical Research Foundation (OMRF) is at the core of the platform being developed by Progentec.
The Lupus Foundation of America estimates that there are as many as 1.5 million lupus (systemic lupus erythematosus or SLE) patients in the U.S. alone. Seen mostly in women between the ages of 15-44, Lupus causes the immune system to recognize and attack the body’s own tissues. Lupus sufferers have periods of flares and remission with organs typically affected including the skin, kidneys, lungs and reproductive organs, as well as the cardiovascular system.
Progentec Diagnostics, led by Sanjiv Sharma and Mohan Purushothaman, is working closely with OMRF’s Judith James, M.D., Ph.D., a world leader in lupus research and an inventor of Progentec’s technology, to further advance and refine the platform and its associated algorithms to fulfill the unmet need of advanced lupus diagnostics. The company’s technologies include highly accurate tests for early diagnosis, a score to track underlying disease activity, and a predictive score for lupus flares. With the current funding round, Progentec plans to conduct a retrospective study at OMRF and prospective studies at OMRF and Mayo Clinic to further refine these algorithms.
“The ability to predict an impending flare represents significant value to lupus patients and their physicians. This test is currently not available and is a focus area for us,” said Sanjiv Sharma, Chairman of Progentec.
“Looking beyond flare prediction, a test to track underlying disease activity will fundamentally change how lupus patients are identified for specific interventions and allows for better management decisions at all levels of the healthcare system,” said Mohan Purushothaman, CEO of Progentec.
OMRF has established a significant focus on lupus. “OMRF has been at the forefront of leading scientific research, especially in the field of lupus,” said Manu Nair, Vice President of Technology Ventures at OMRF. “Progentec is going on a trajectory that we have traversed in the past, and we believe that our science, combined with the entrepreneurial and management skills brought in by Progentec, will successfully bring these tests to the market.”
“We are pleased to work with OCA Ventures and Mayo Clinic on this promising, Oklahoma-born project,” said Scott Meacham, President and CEO of i2E Inc., “It is important to work together to identify and develop technologies like these in their early stages when they most need help.”
Mayo Clinic Ventures found Progentec’s technology aligned with their clinical interest in lupus, especially in managing patients with a diagnostic to improve patient care while potentially reducing clinical costs. “We are excited to work with Progentec and OMRF to advance this technology and hopefully bring about a change in how lupus patients are diagnosed, managed and treated,” said Andrew Danielsen, Vice Chair, Mayo Clinic Ventures.
Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
Currently, no test exists that can predict when a lupus flare will occur. Therefore, Progentec’s test could have a significant impact for patients at risk of organ damage or death caused by lupus flares that cannot otherwise be accurately predicted.
How to get mental health help where there are no doctors. Telepsychiatry.
Textbook economics teaches that, in a free market, supply rises to meet demand until price reaches an equilibrium. When it comes to mental health services, though, the supply of psychiatrists is declining despite widespread need, resulting in patients not getting treatment in a timely manner.
Regroup’s mission is to fill that void by supplying credentialed and fully vetted clinicians—psychiatrists, social workers and advanced practice nurses—who can “see” patients via a secure video platform that’s HIPAA-compliant. “Literally, the only difference is our clinicians are in two dimensions,” Cohn says.
The for-profit company’s customers are not the individuals themselves, but hospitals, primary care clinics, correctional institutions and community-based outpatient centers through which people access health care. In the Chicago market, clients include Sinai Health System, Oak Street Health and Metropolitan Family Services. They’re billed monthly for services rendered and reimbursed by patients’ insurers or government programs such as Medicaid and Medicare.
Cohn, 37, who grew up on the North Shore, says he always had an interest in both technology and mental health, but didn’t see himself becoming a clinician. After majoring in economics at Colorado College, spending two years in Guatemala with the Peace Corps and managing sales and services in Latin America and Europe for CEB, formerly known as Corporate Executive Board, he earned his MBA at IE Business School in Madrid, where he hatched the idea for Regroup Therapy as a class project.
He started Regroup with $60,000 from friends, family and his own savings. The company has raised $8.4 million from investors including OSF Ventures, Hyde Park Angels, OCA Ventures and Frist Cressey Ventures.
Revenue jumped from less than $500,000 last year to a projected $10 million-plus in annual recurring revenue by year-end. Regroup now employs 23 full-time staffers in its headquarters in Ravenswood, IL and serves nearly 50 health entities with a network of more than 3,000 clinicians. Roughly half of treatment hours are provided by clinicians who work full time for Regroup; the remainder are part-time contractors. Clinicians are paid $45 to $300 per hour. Full-timers also receive benefits such as health care coverage, medical malpractice insurance and a 401(k) retirement plan.
At its 2017 awards program Nov. 9 in Chicago, the Illinois Telehealth Initiative recognized Regroup with an award for Advancing Telehealth by Innovation. Nancy Kaszak, the initiative’s director, cites Regroup’s easy-to-use video platform and system integration as strengths in the telehealth field. “Hospitals are big on their records and their systems,” she says, “and if you can’t integrate into that system, it becomes an issue.”
Forbes 30 under 30: Moving Analytics co-founders, Adelanwa Adesanya & Shuo Qiao
Cofounders, Moving Analytics
Impossible Objects LLC has raised a $6.4 million Series A investment round led by OCA Ventures and with participation from IDEA Fund Partners, a technology-focused early stage venture capital firm, Mason Avenue Investments, Huizenga Capital Management, and Inflection Equity Partners. With this latest round, Impossible Objects has raised a total of more than $9 million.
“We’ve seen incredible momentum as more corporations are looking to additive manufacturing for production purposes and not just prototypes or low volumes. These companies need strong parts that can be made fast,” says Robert Swartz, founder and chairman of Impossible Objects. “We’re delighted to work with our investment partners to meet this massive opportunity.”
This spring, the company debuted its pilot Model One printer and acquired its first customer, the Fortune 500 Jabil Inc., a product solutions company providing comprehensive electronics design, production and product management services to global electronics and technology companies. The Model One won the Innovation Award at the RAPID + TCT 3D Printing and Additive Manufacturing conference for the service or product that will have the greatest impact on the industry.
Impossible Objects’ composite-based additive manufacturing method (CBAM) leverages high-speed 2D graphics technologies and enables companies to use a range of composite materials, including carbon fiber, Kevlar and fiberglass together with PEEK and other high performance polymers, to build strong, lightweight parts at scale.
The Model One will be commercially available in 2018, and pilot versions of the machine are available now on a selective basis.
SpotHero has its foot on the gas, and it’s not slowing down.
The Chicago-based on-demand parking startup announced Tuesday that it has raised $30 million in new funding, bringing the company’s total venture capital to date to $57.5 million.
SpotHero said it will uses the Series C funding to expand into more markets in the United States and Canada, grow its B2B offerings, and invest in new technology to make its app work with autonomous vehicles. It also plans to roll out other new features like mobile payment and operations apps for parking management companies.
“We continue to see unprecedented growth, hire extremely talented individuals and have an exponentially expanding, loyal customer base who love the value we add in their daily lives,” Mark Lawrence, CEO of SpotHero, said in a statement.
Investors in the round include Insight Venture Partners, Global Founders Capital, OCA Ventures, Chicago Ventures, Levy Family Partners, Bullpen Capital, Pritzker Group Venture Capital, Draper Associates, Sam Yagan, Corazon Capital, Daniel Hoffer and Math Venture Partners.
SpotHero, founded in 2011, connects drivers to parking decks and other off-street parking. The company said revenue grew 100 percent year-over-year in 2016.
In April, SpotHero acquired competitor Parking Panda in a deal that beefed up its presence on the East Coast and Canada. Parking Panda also helped expand SpotHero’s B2B operations, as it has deals with several pro sports teams and other venues to offer on-demand parking.
Parking Panda was SpotHero’s second acquisition in two years; it bought San Francisco’s ParkPlease in 2015.
One of SpotHero’s remaining competitors is Chicago-based ParkWhiz, which has raised $36 million since it launched in 2006.
“The future of urban transportation is so exciting because of such rapid changes – from self-driving cars, to instant, cashless payments, to making cities greener by decreasing carbon footprints,” Ludwig Ensthaler, partner at GFC, added in the statement. “There’s no doubt that SpotHero is at the forefront of the evolution of parking, leading the industry with its people, marketplace, products and services.”
Read more at: https://www.americaninno.com/chicago/
Levyx Inc., whose high-performance, ultra-low latency data processing software dramatically reduces Big Data infrastructure costs, revealed today record shattering independent testing results performed by the Securities Technology Analysis Center (STAC®) using the STAC-A3 benchmarking suite.
Levyx broke the performance record running the benchmark on four 64-vCPU Google Cloud nodes equipped with SSDs while running Apache Spark and Levyx’s Xenon software. The net result was 32X the performance employing much less equipment in comparison to the baseline STAC-A3 benchmark which used a 14-node (24 cores each) disk-based Map-Reduce Hadoop cluster.
STAC-A3 is the industry’s primary performance benchmark suite for the infrastructure that banks, hedge funds and other trading firms use to backtest potential trading algorithms. Peter Lankford, Director of STAC, said: “Trading firms in the STAC Benchmark Council specified the STAC-A3 benchmarks in order to measure the potential of software and hardware innovations to accelerate backtesting. The competitive pressure on firms to bring smarter algorithms to market in less time, together with the increasing use of machine learning to automate development of candidate algorithms, has put backtesting on the critical path to revenue. Levyx’s use of STAC-A3 shows that the company is putting serious focus on the industry’s desire to speed up this key workload.”
Reza Sadri, CEO of Levyx, said: “Since the financial sector typically pushes the envelope for low-latency technologies, our results for this class of sophisticated backtesting validate our performance benefits in a real-world application and point to an exciting market opportunity within the financial space. Similarly, these performance benefits can also accelerate the Time-To-Value in other large markets, such as analyzing trends in insurance, credit scores and consumer sentiment, to name a few. In addition, the STAC results highlight that we drastically reduce the data center footprint and related costs (in the cloud or on-premise).”
Levyx’s Xenon™ leverages the high-performance nature of Levyx’s Helium™ core engine and extends it into a low latency, scalable data analytics solution. Xenon is designed to manage the retrieval, processing, and indexing of very large datasets, i.e., collections of billions of objects, spread across a tightly coupled cluster of servers, each with multi-terabyte persistent storage capabilities. More specifically, Xenon is a distributed database system having the following functional capabilities:
- Core SQL functionality: filter, projection, selection, sort, join, groupby, and aggregates on structured data, i.e., schema-based tables.
- Support for random lookup and neighborhood search using an index rather than scan and filter.
- Tightly integrate with the Apache Spark system for ease of deployment and use (also fully capable to function in native mode, or serve as an off-load layer for other big-platforms and systems).
- Scale with the number of cores in the cluster and use SSDs (or other high-bandwidth, low latency persistent storage) as a persistent memory layer for large, live datasets.
The efficiency with which Xenon can process massive workloads can also be applied in the processing of similar large-scale data sets in other applications within the financial sector, as well as in different vertical industries such as Government, Internet of Things (IoT), Oil and Gas, Machine Learning, Artificial Intelligence, and Cybersecurity.
About Levyx Inc.
Levyx’s software solutions fundamentally disrupt the economics of Big-Data applications, bringing the benefits of high-speed Big-Data processing to the masses. No longer reserved for the largest enterprises, Levyx technology can process hundreds of millions of queries per second on commodity servers on a few nodes, making Big-Data processing much more accessible to organizations of all sizes. More information is available at www.levyx.com.
STAC® is a technology-research firm that facilitates the STAC Benchmark™ Council (www.STACresearch.com/council), an organization of leading financial institutions and technology vendors that specifies standard ways to assess technologies used in the financial markets. The Council is active in an expanding range of low-latency, big-compute, and Big-Data workloads.
The STAC-A3 benchmark report may be downloaded for free by going to:
Levyx, the Levyx logo, Helium, and Xenon are trademarks of Levyx Inc. STAC and all STAC names are trademarks or registered trademarks of the Securities Technology Analysis Center, LLC. All other trademarks or brand names referred in this press release are the property of their respective owners.
Regroup Therapy has had a whirlwind of a year.
The Chicago-based startup, which uses video technology to deliver mental health services to underserved areas, announced on Thursday that it has raised a $6 million Series A round of funding led by OSF Ventures.
Regroup Therapy, which raised a $1.8 million seed round last spring, has seen its annual recurring revenues grow by nearly 4,000 percent over the past year.
“We were aiming for half a million dollars annual revenues last year, but we’re on track to book more than $4 million,” said founder and CEO David Cohn. “Our seed funding allowed us to invest in more people. When we got away from trying to do three or four times more than is humanly possible, we discovered that our processes were actually really good — we just needed more people out there.”
Read more (via Built In Chicago) at: http://www.builtinchicago.org/2017/06/15/regroup-therapy-raises-6m
Regroup Therapy lands $6M to give mental health care over video chat
Chicago-based Regroup Therapy, which lets mental health professionals virtually meet with patients at a variety of institutions, has raised more than $6 million in Series A funding, it announced Thursday.
It has been a period of notable growth for Regroup, which was founded in 2011 and bootstrapped until last year.
Revenue at the telehealth company is up significantly since it raised its $1.8 million seed round in April 2016, said CEO and founder David Cohn. It currently has more than $4.5 million in annual revenue under contract, whereas early last year its annualized revenue was about $100,000, he said.
“(We) have a health care system that is increasingly incentivized to provide better care earlier for patients,” Cohn said. “You can’t do that without providing high-quality mental-health care earlier.”
- Google’s Android Assistant to Partner with SpotHero through Android Auto January 10, 2018
- SwipeSense raises $10.6M for Internet of Things push December 7, 2017
- Solovis Strengthens Analytics Capabilities with Acquisition of Madrone Software December 5, 2017
- Progentec Diagnostics Raises $1.25M to Predict Lupus Flare-ups November 27, 2017